Literature DB >> 16717266

Balancing the cyclooxygenase portfolio.

Paul W Armstrong1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16717266      PMCID： PMC1459888          DOI： 10.1503/cmaj.060471

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Effect of ibuprofen on cardioprotective effect of aspirin.

Authors:  T M MacDonald; L Wei
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

Review 2.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Authors:  Tilo Grosser; Susanne Fries; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  Vioxx, the implosion of Merck, and aftershocks at the FDA.

Authors:  Richard Horton
Journal:  Lancet       Date:  2004 Dec 4-10       Impact factor: 79.321

4.  The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults.

Authors:  Linda E Lévesque; James M Brophy; Bin Zhang
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

Review 5.  The double-edged sword of COX-2 selective NSAIDs.

Authors:  James M Wright
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

Review 6.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

7.  Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors.

Authors:  Linda E Lévesque; James M Brophy; Bin Zhang
Journal:  CMAJ       Date:  2006-05-02       Impact factor: 8.262

8.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors:  C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

9.  Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.

Authors:  David J Graham; David Campen; Rita Hui; Michele Spence; Craig Cheetham; Gerald Levy; Stanford Shoor; Wayne A Ray
Journal:  Lancet       Date:  2005 Feb 5-11       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.